FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:399-405 February 11, 1993 Number 6 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The adult respiratory distress syndrome is characterized by pulmonary hypertension and right-to-left shunting of venous blood. We investigated whether inhaling nitric oxide gas would cause selective vasodilation of ventilated lung regions, thereby reducing pulmonary hypertension and improving gas exchange.

Methods Nine of 10 consecutive patients with severe adult respiratory distress syndrome inhaled nitric oxide in two concentrations for 40 minutes each. Hemodynamic variables, gas exchange, and ventilation-perfusion distributions were measured by means of multiple inert-gas-elimination techniques during nitric oxide inhalation; the results were compared with those obtained during intravenous infusion of prostacyclin. Seven patients were treated with continuous inhalation of nitric oxide in a concentration of 5 to 20 parts per million (ppm) for 3 to 53 days.

Results Inhalation of nitric oxide in a concentration of 18 ppm reduced the mean (±SE) pulmonary-artery pressure from 37 ±3 mm Hg to 30 ±2 mm Hg (P = 0.008) and decreased intrapulmonary shunting from 36 ±5 percent to 31 ±5 percent (P = 0.028). The ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO₂/FiO₂), an index of the efficiency of arterial oxygenation, increased during nitric oxide administration from 152 ±15 mm Hg to 199 ±23 mm Hg (P = 0.008), although the mean arterial pressure and cardiac output were unchanged. Infusion of prostacyclin reduced pulmonary-artery pressure but increased intrapulmonary shunting and reduced the PaO₂/FiO₂ and systemic arterial pressure. Continuous nitric oxide inhalation consistently lowered the pulmonary-artery pressure and augmented the PaO₂/FiO₂ for 3 to 53 days.

Conclusions Inhalation of nitric oxide by patients with severe adult respiratory distress syndrome reduces the pulmonary-artery pressure and increases arterial oxygenation by improving the matching of ventilation with perfusion, without producing systemic vasodilation. Randomized, blinded trials will be required to determine whether inhaled nitric oxide will improve outcome.

Source Information

From the Klinik fur Anaesthesiologie und operative Intensivmedizin, Universitatsklinikum Rudolf Virchow, Freie Universitat Berlin, Berlin (R.R., K.J.F., F.L., K.S., U.P.), and the Department of Anaesthesia, Harvard Medical School at Massachusetts General Hospital, Boston (W.M.Z.). The Massachusetts General Hospital has filed for a patent (pending) on the respiratory uses of nitric oxide.

Address reprint requests to Dr. Falke at Klinik fur Anaesthesiologie und operative Intensivmedizin, Universitatsklinikum Rudolf Virchow/Wedding, Freie Universitat Berlin, Augustenburger Platz 1, 1000 Berlin 65, Germany.

Full Text of this Article

Related Letters:

Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
Sahebjami H., Monchi M., Brunet F., Dinh-Xuan A. T., Zapol W. M., Falke K. J., Rossaint R.
Extract | Full Text  
N Engl J Med 1993; 329:206-207, Jul 15, 1993. Correspondence

This article has been cited by other articles:

• Ghofrani, H. A., Wilkins, M. W., Rich, S. (2008). Uncertainties in the Diagnosis and Treatment of Pulmonary Arterial Hypertension. Circulation 118: 1195-1201 [Abstract] [Full Text]  
• Karanicolas, P. J., Kunz, R., Guyatt, G. H. (2008). Point: Evidence-Based Medicine Has a Sound Scientific Base. Chest 133: 1067-1071 [Full Text]  
• Petersen, B., Deja, M., Bartholdy, R., Donaubauer, B., Laudi, S., Francis, R. C. E., Boemke, W., Kaisers, U., Busch, T. (2008). Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294: R601-R605 [Abstract] [Full Text]  
• Evgenov, O. V., Kohane, D. S., Bloch, K. D., Stasch, J.-P., Volpato, G. P., Bellas, E., Evgenov, N. V., Buys, E. S., Gnoth, M. J., Graveline, A. R., Liu, R., Hess, D. R., Langer, R., Zapol, W. M. (2007). Inhaled Agonists of Soluble Guanylate Cyclase Induce Selective Pulmonary Vasodilation. Am. J. Respir. Crit. Care Med. 176: 1138-1145 [Abstract] [Full Text]  
• Coggins, M. P., Bloch, K. D. (2007). Nitric Oxide in the Pulmonary Vasculature. Arterioscler. Thromb. Vasc. Bio. 27: 1877-1885 [Abstract] [Full Text]  
• Bloch, K. D., Ichinose, F., Roberts, J. D. Jr., Zapol, W. M. (2007). Inhaled NO as a therapeutic agent. Cardiovasc Res 75: 339-348 [Abstract] [Full Text]  
• Calfee, C. S., Matthay, M. A. (2007). Nonventilatory Treatments for Acute Lung Injury and ARDS. Chest 131: 913-920 [Abstract] [Full Text]  
• Donaubauer, B., Busch, T., Lachmann, R., Deja, M., Petersen, B., Francis, R., Trager, A., Ebsen, M., Boemke, W., Kaisers, U. (2006). Low-Dose Inhalation of an Endothelin-A Receptor Antagonist in Experimental Acute Lung Injury: ET-1 Plasma Concentration and Pulmonary Inflammation.. Exp. Biol. Med. 231: 960-966 [Abstract] [Full Text]  
• Busch, T., Petersen, B., Deja, M., Donaubauer, B., Laudi, S., Jaumann, S., Bercker, S., Boemke, W., Kaisers, U. (2006). Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injury.. Exp. Biol. Med. 231: 974-978 [Abstract] [Full Text]  
• Cepkova, M., Matthay, M. A. (2006). Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.. J Intensive Care Med 21: 119-143 [Abstract]  
• Oishi, P., Grobe, A., Benavidez, E., Ovadia, B., Harmon, C., Ross, G. A., Hendricks-Munoz, K., Xu, J., Black, S. M., Fineman, J. R. (2006). Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L359-L366 [Abstract] [Full Text]  
• Griffiths, M. J.D., Evans, T. W. (2005). Inhaled Nitric Oxide Therapy in Adults. NEJM 353: 2683-2695 [Full Text]  
• Fan, E., Needham, D. M., Stewart, T. E. (2005). Ventilatory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome. JAMA 294: 2889-2896 [Abstract] [Full Text]  
• Sandifer, B. L., Brigham, K. L., Lawrence, E. C., Mottola, D., Cuppels, C., Parker, R. E. (2005). Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation. J. Appl. Physiol. 99: 2363-2368 [Abstract] [Full Text]  
• Journois, D., Baufreton, C., Mauriat, P., Pouard, P., Vouhe, P., Safran, D. (2005). Effects of Inhaled Nitric Oxide Administration on Early Postoperative Mortality in Patients Operated for Correction of Atrioventricular Canal Defects. Chest 128: 3537-3544 [Abstract] [Full Text]  
• Kinsella, J. P., Parker, T. A., Davis, J. M., Abman, S. H. (2005). Superoxide Dismutase Improves Gas Exchange and Pulmonary Hemodynamics in Premature Lambs. Am. J. Respir. Crit. Care Med. 172: 745-749 [Abstract] [Full Text]  
• Hauser, B., Bracht, H., Matejovic, M., Radermacher, P., Venkatesh, B. (2005). Nitric Oxide Synthase Inhibition in Sepsis? Lessons Learned from Large-Animal Studies. Anesth. Analg. 101: 488-498 [Abstract] [Full Text]  
• Ioannidis, J. P. A. (2005). Contradicted and Initially Stronger Effects in Highly Cited Clinical Research. JAMA 294: 218-228 [Abstract] [Full Text]  
• Van Meurs, K. P., Wright, L. L., Ehrenkranz, R. A., Lemons, J. A., Ball, M. B., Poole, W. K., Perritt, R., Higgins, R. D., Oh, W., Hudak, M. L., Laptook, A. R., Shankaran, S., Finer, N. N., Carlo, W. A., Kennedy, K. A., Fridriksson, J. H., Steinhorn, R. H., Sokol, G. M., Konduri, G. G., Aschner, J. L., Stoll, B. J., D'Angio, C. T., Stevenson, D. K., the Preemie Inhaled Nitric Oxide Study, (2005). Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure. NEJM 353: 13-22 [Abstract] [Full Text]  
• Dembinski, R., Brackhahn, W., Henzler, D., Rott, A., Bensberg, R., Kuhlen, R., Rossaint, R. (2005). Cardiopulmonary effects of iloprost in experimental acute lung injury. Eur Respir J 25: 81-87 [Abstract] [Full Text]  
• Lowson, S. M. (2004). Alternatives to nitric oxide. Br Med Bull 70: 119-131 [Abstract] [Full Text]  
• Marczin, N. (2004). Editorial I: Tiny wonders of tiny impurities of nitrous oxide during anaesthesia. Br J Anaesth 93: 619-623 [Full Text]  
• Tsai, B. M., Wang, M., Turrentine, M. W., Mahomed, Y., Brown, J. W., Meldrum, D. R. (2004). Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies. Ann. Thorac. Surg. 78: 360-368 [Abstract] [Full Text]  
• Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., Folkerts, G. (2004). Nitric Oxide in Health and Disease of the Respiratory System. Physiol. Rev. 84: 731-765 [Abstract] [Full Text]  
• Ichinose, F., Roberts, J. D. Jr, Zapol, W. M. (2004). Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential. Circulation 109: 3106-3111 [Full Text]  
• Ghofrani, H. A., Pepke-Zaba, J., Barbera, J. A., Channick, R., Keogh, A. M., Gomez-Sanchez, M. A., Kneussl, M., Grimminger, F. (2004). Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43: 68S-72S [Abstract] [Full Text]  
• Thelitz, S., Bekker, J. M., Ovadia, B., Stuart, R. B., Johengen, M. J., Black, S. M., Fineman, J. R. (2004). Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs. J. Thorac. Cardiovasc. Surg. 127: 1285-1292 [Abstract] [Full Text]  
• Taylor, R. W., Zimmerman, J. L., Dellinger, R. P., Straube, R. C., Criner, G. J., Davis, K. Jr, Kelly, K. M., Smith, T. C., Small, R. J. (2004). Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury: A Randomized Controlled Trial. JAMA 291: 1603-1609 [Abstract] [Full Text]  
• Adhikari, N., Granton, J. T. (2004). Inhaled Nitric Oxide for Acute Lung Injury: No Place for NO?. JAMA 291: 1629-1631 [Full Text]  
• De Wet, C. J., Affleck, D. G., Jacobsohn, E., Avidan, M. S., Tymkew, H., Hill, L. L., Zanaboni, P. B., Moazami, N., Smith, J. R. (2004). Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J. Thorac. Cardiovasc. Surg. 127: 1058-1067 [Abstract] [Full Text]  
• Ghofrani, H.A., Friese, G., Discher, T., Olschewski, H., Schermuly, R.T., Weissmann, N., Seeger, W., Grimminger, F., Lohmeyer, J. (2004). Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension. Eur Respir J 23: 321-326 [Abstract] [Full Text]  
• Sokol, J., Jacobs, S. E., Bohn, D. (2003). Inhaled Nitric Oxide for Acute Hypoxic Respiratory Failure in Children and Adults: A Meta-analysis. Anesth. Analg. 97: 989-998 [Abstract] [Full Text]  
• Lowson, S. M. (2003). Nitric Oxide Signaling and Clinical Alternatives to Nitric Oxide. SEMIN CARDIOTHORAC VASC ANESTH 7: 239-252 [Abstract]  
• Gessner, C., Hammerschmidt, S., Kuhn, H., Lange, T., Engelmann, L., Schauer, J., Wirtz, H. (2003). Exhaled Breath Condensate Nitrite and Its Relation to Tidal Volume in Acute Lung Injury. Chest 124: 1046-1052 [Abstract] [Full Text]  
• Schermuly, R.T., Leuchte, H., Ghofrani, H.A., Weissmann, N., Rose, F., Kohstall, M., Olschewski, H., Schudt, C., Grimminger, F., Seeger, W., Walmrath, D. (2003). Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure. Eur Respir J 22: 342-347 [Abstract] [Full Text]  
• de Franceschi, L., Baron, A., Scarpa, A., Adrie, C., Janin, A., Barbi, S., Kister, J., Rouyer-Fessard, P., Corrocher, R., Leboulch, P., Beuzard, Y. (2003). Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 102: 1087-1096 [Abstract] [Full Text]  
• Jones, A.T., Hansell, D.M., Evans, T.W. (2003). Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO. Eur Respir J 21: 855-861 [Abstract] [Full Text]  
• Moloney, E.D., Evans, T.W. (2003). Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J 21: 720-727 [Abstract] [Full Text]  
• Gerlach, H., Keh, D., Semmerow, A., Busch, T., Lewandowski, K., Pappert, D. M., Rossaint, R., Falke, K. J. (2003). Dose-Response Characteristics during Long-Term Inhalation of Nitric Oxide in Patients with Severe Acute Respiratory Distress Syndrome: A Prospective, Randomized, Controlled Study. Am. J. Respir. Crit. Care Med. 167: 1008-1015 [Abstract] [Full Text]  
• Natori, S., Hasebe, N., Jin, Y.-T., Matsusaka, T., Ido, A., Matsuhashi, H., Ihara, T., Kikuchi, K. (2003). Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure. Am. J. Respir. Crit. Care Med. 167: 895-901 [Abstract] [Full Text]  
• Weiner, D. L., Hibberd, P. L., Betit, P., Cooper, A. B., Botelho, C. A., Brugnara, C. (2003). Preliminary Assessment of Inhaled Nitric Oxide for Acute Vaso-occlusive Crisis in Pediatric Patients With Sickle Cell Disease. JAMA 289: 1136-1142 [Abstract] [Full Text]  
• McNeil, K, Dunning, J, Morrell, N W (2003). The pulmonary physician in critical care * 13: The pulmonary circulation and right ventricular failure in the ITU. Thorax 58: 157-162 [Abstract] [Full Text]  
• Dukelow, A. M., Weicker, S., Karachi, T. A., Razavi, H. M., McCormack, D. G., Joseph, M. G., Mehta, S. (2002). Effects of Nebulized Diethylenetetraamine-NONOate in a Mouse Model of Acute Pseudomonas aeruginosa Pneumonia. Chest 122: 2127-2136 [Abstract] [Full Text]  
• Fujita, M., Mason, R. J., Cool, C., Shannon, J. M., Hara, N., Fagan, K. A. (2002). Pulmonary hypertension in TNF-alpha -overexpressing mice is associated with decreased VEGF gene expression. J. Appl. Physiol. 93: 2162-2170 [Abstract] [Full Text]  
• Kirov, M. Y., Evgenov, O. V., Kuklin, V. N., Virag, L., Pacher, P., Southan, G. J., Salzman, A. L., Szabo, C., Bjertnaes, L. J. (2002). Aerosolized Linear Polyethylenimine-Nitric Oxide/Nucleophile Adduct Attenuates Endotoxin-induced Lung Injury in Sheep. Am. J. Respir. Crit. Care Med. 166: 1436-1442 [Abstract] [Full Text]  
• Sticher, J., Scholz, S., Boning, O., Schermuly, R. T., Schumacher, C., Walmrath, D., Hempelmann, G. (2002). Small-Dose Nitric Oxide Improves Oxygenation During One-Lung Ventilation: An Experimental Study. Anesth. Analg. 95: 1557-1562 [Abstract] [Full Text]  
• Rassaf, T., Kleinbongard, P., Preik, M., Dejam, A., Gharini, P., Lauer, T., Erckenbrecht, J., Duschin, A., Schulz, R., Heusch, G., Feelisch, M., Kelm, M. (2002). Plasma Nitrosothiols Contribute to the Systemic Vasodilator Effects of Intravenously Applied NO: Experimental and Clinical Study on the Fate of NO in Human Blood. Circ. Res. 91: 470-477 [Abstract] [Full Text]  
• Afifi, S. (2002). Lung Protective Ventilation Strategies. SEMIN CARDIOTHORAC VASC ANESTH 6: 259-269 [Abstract]  
• Cranshaw, J, Griffiths, M J D, Evans, T W (2002). The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS. Thorax 57: 823-829 [Abstract] [Full Text]  
• Tomlinson, L, Bellingan, G. (2002). Trauma and acute lung injury. Trauma 4: 147-157 [Abstract]  
• Tornberg, D.C.F., Marteus, H., Schedin, U., Alving, K., Lundberg, J.O.N., Weitzberg, E. (2002). Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients. Eur Respir J 19: 859-864 [Abstract] [Full Text]  
• Trummer, G., Berchtold-Herz, M., Martin, J., Beyersdorf, F. (2002). Successful treatment of pulmonary hypertension with inhaled nitric oxide after pulmonary embolectomy. Ann. Thorac. Surg. 73: 1299-1301 [Abstract] [Full Text]  
• Heinonen, E., Nyman, G., Merilainen, P., Hogman, M. (2002). Effect of different pulses of nitric oxide on venous admixture in the anaesthetized horse. Br J Anaesth 88: 394-398 [Abstract] [Full Text]  
• Maxey, T. S., Smith, C. D., Kern, J. A., Tribble, C. G., Jones, D. R., Kron, I. L., Crosby, I. K. (2002). Beneficial effects of inhaled nitric oxide in adult cardiac surgical patients. Ann. Thorac. Surg. 73: 529-533 [Abstract] [Full Text]  
• Ho, T. B L, Rhodes, A. (2002). Nitric oxide and prostacyclin in acute interstitial pneumonia. JRSM 95: 35-37 [Full Text]  
• SCHERMULY, R. T., KRUPNIK, E., TENOR, H., SCHUDT, C., WEISSMANN, N., ROSE, F., GRIMMINGER, F., SEEGER, W., WALMRATH, D., GHOFRANI, H. A. (2001). Coaerosolization of Phosphodiesterase Inhibitors Markedly Enhances the Pulmonary Vasodilatory Response to Inhaled Iloprost in Experimental Pulmonary Hypertension . Maintenance of Lung Selectivity. Am. J. Respir. Crit. Care Med. 164: 1694-1700 [Abstract] [Full Text]  
• Brower, R. G., Ware, L. B., Berthiaume, Y., Matthay, M. A. (2001). Treatment of ARDS. Chest 120: 1347-1367 [Abstract] [Full Text]  
• Stuart-Smith, K., Jeremy, J. Y. (2001). Microvessel damage in acute respiratory distress syndrome: the answer may not be NO. Br J Anaesth 87: 272-279 [Abstract] [Full Text]  
• Maurenbrecher, H., Lamy, M., Deby-Dupont, G., Frascarolo, P., Hedenstierna, G. (2001). An Animal Model of Response and Nonresponse to Inhaled Nitric Oxide in Endotoxin-Induced Lung Injury. Chest 120: 573-581 [Abstract] [Full Text]  
• Thom, S. R., Fisher, D., Manevich, Y. (2001). Roles for platelet-activating factor and {middle dot}NO-derived oxidants causing neutrophil adherence after CO poisoning. Am. J. Physiol. Heart Circ. Physiol. 281: H923-H930 [Abstract] [Full Text]  
• RIALP, G., BETBESE, A. J., PEREZ-MARQUEZ, M., MANCEBO, J. (2001). Short-term Effects of Inhaled Nitric Oxide and Prone Position in Pulmonary and Extrapulmonary Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 164: 243-249 [Abstract] [Full Text]  
• Weiner, R. E., Sasso, D. E., Gionfriddo, M. A., Thrall, R. S., Syrbu, S., Smilowitz, H. M., Vento, J. (2001). Early Detection of Oleic Acid-Induced Lung Injury in Rats Using 111In-Labeled Anti-Rat Intercellular Adhesion Molecule-1. JNM 42: 1109-1115 [Abstract] [Full Text]  
• KOBAYASHI, T., GABAZZA, E. C., SHIMIZU, S., YASUI, H., YUDA, H., HATAJI, O., MARUYAMA, K., YAMAUCHI, T., SUZUKI, K., ADACHI, Y., TAGUCHI, O. (2001). Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice. Am. J. Respir. Crit. Care Med. 163: 1676-1682 [Abstract] [Full Text]  
• Baldauf, M., Silver, P., Sagy, M. (2001). Evaluating the Validity of Responsiveness to Inhaled Nitric Oxide in Pediatric Patients With ARDS : An Analytic Tool. Chest 119: 1166-1172 [Abstract] [Full Text]  
• NAGAYA, N., UEMATSU, M., OYA, H., SATO, N., SAKAMAKI, F., KYOTANI, S., UENO, K., NAKANISHI, N., YAMAGISHI, M., MIYATAKE, K. (2001). Short-term Oral Administration of L-Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 163: 887-891 [Abstract] [Full Text]  
• Sheel, A. W., Edwards, M. R., Hunte, G. S., McKenzie, D. C. (2001). Influence of inhaled nitric oxide on gas exchange during normoxic and hypoxic exercise in highly trained cyclists. J. Appl. Physiol. 90: 926-932 [Abstract] [Full Text]  
• Bushman, G. (2001). Essentials of Nitric Oxide for the Pediatric (Cardiac) Anesthesiologist. SEMIN CARDIOTHORAC VASC ANESTH 5: 79-90 [Abstract]  
• Stitt, J. T., DuBois, A. B. (2001). The lung diffusing capacity for nitric oxide in rats is increased during endotoxemia. J. Appl. Physiol. 90: 1049-1056 [Abstract] [Full Text]  
• Perez-Penate, G., Julia-Serda, G., Pulido-Duque, J. M., Gorriz-Gomez, E., Cabrera-Navarro, P. (2001). One-Year Continuous Inhaled Nitric Oxide for Primary Pulmonary Hypertension. Chest 119: 970-973 [Abstract] [Full Text]  
• Baldus, S., Castro, L., Eiserich, J. P., Freeman, B. A. (2001). Is {middle dot}NO News Bad News in Acute Respiratory Distress Syndrome?. Am. J. Respir. Crit. Care Med. 163: 308-310 [Full Text]  
• Kleeberger, S. R., Reddy, S. P. M., Zhang, L.-Y., Cho, H.-Y., Jedlicka, A. E. (2001). Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L326-L333 [Abstract] [Full Text]  
• McMullan, D. M., Bekker, J. M., Johengen, M. J., Hendricks-Munoz, K., Gerrets, R., Black, S. M., Fineman, J. R. (2001). Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am. J. Physiol. Heart Circ. Physiol. 280: H777-H785 [Abstract] [Full Text]  
• Nurozler, F., Argenziano, M., Ginsburg, M. E. (2001). Nitric oxide usage after posttraumatic pneumonectomy. Ann. Thorac. Surg. 71: 364-366 [Abstract] [Full Text]  
• Cockrill, B. A., Kacmarek, R. M., Fifer, M. A., Bigatello, L. M., Ginns, L. C., Zapol, W. M., Semigran, M. J. (2001). Comparison of the Effects of Nitric Oxide, Nitroprusside, and Nifedipine on Hemodynamics and Right Ventricular Contractility in Patients With Chronic Pulmonary Hypertension. Chest 119: 128-136 [Abstract] [Full Text]  
• Kornecki, A., Frndova, H., Coates, A. L., Shemie, S. D. (2001). 4A Randomized Trial of Prolonged Prone Positioning in Children With Acute Respiratory Failure. Chest 119: 211-218 [Abstract] [Full Text]  
• Krasuski, R. A., Warner, J. J., Wang, A., Harrison, J. K., Tapson, V. F., Bashore, T. M. (2000). Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 36: 2204-2211 [Abstract] [Full Text]  
• King, R., Esmail, M., Mahon, S., Dingley, J., Dwyer, S. (2000). Use of nitric oxide for decompensated right ventricular failure and circulatory shock after cardiac arrest. Br J Anaesth 85: 628-631 [Abstract] [Full Text]  
• TSUCHIYA, M., TOKAI, H., TAKEHARA, Y., HARAGUCHI, Y., ASADA, A., UTSUMI, K., INOUE, M. (2000). Interrelation between Oxygen Tension and Nitric Oxide in the Respiratory System. Am. J. Respir. Crit. Care Med. 162: 1257-1261 [Abstract] [Full Text]  
• Smulders, Y. M. (2000). Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48: 23-33 [Abstract] [Full Text]  
• Jaillard, S., Riou, Y., Klosowski, S., Cneude, F., Fialdes, P., Codaccioni, X., Lequien, P., Storme, L. (2000). Effects of inhaled nitric oxide on gas exchange and acute lung injury in premature lambs with moderate hyaline membrane disease. Eur. J. Cardiothorac. Surg. 18: 334-341 [Abstract] [Full Text]  
• Neviere, R., Guery, B., Mordon, S., Zerimech, F., Charre, S., Wattel, F., Chopin, C. (2000). Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats. Am. J. Physiol. Heart Circ. Physiol. 278: H1783-H1790 [Abstract] [Full Text]  
• Ware, L. B., Matthay, M. A. (2000). The Acute Respiratory Distress Syndrome. NEJM 342: 1334-1349 [Full Text]  
• Hasuda, T., Satoh, T., Shimouchi, A., Sakamaki, F., Kyotani, S., Matsumoto, T., Goto, Y., Nakanishi, N. (2000). Improvement in Exercise Capacity With Nitric Oxide Inhalation in Patients With Precapillary Pulmonary Hypertension. Circulation 101: 2066-2070 [Abstract] [Full Text]  
• CHRISTENSON, J., LAVOIE, A., O'CONNOR, M., BHORADE, S., POHLMAN, A., HALL, J. B. (2000). The Incidence and Pathogenesis of Cardiopulmonary Deterioration after Abrupt Withdrawal of Inhaled Nitric Oxide. Am. J. Respir. Crit. Care Med. 161: 1443-1449 [Abstract] [Full Text]  
• Rajek, A., Pernerstorfer, T., Kastner, J., Mares, P., Grabenwoger, M., Sessler, D. I., Grubhofer, G., Hiesmayr, M. (2000). Inhaled Nitric Oxide Reduces Pulmonary Vascular Resistance More Than Prostaglandin E1 During Heart Transplantation. Anesth. Analg. 90: 523-530 [Abstract] [Full Text]  
• Schermuly, R. T., Roehl, A., Weissmann, N., Ghofrani, H. A., Schudt, C., Tenor, H., Grimminger, F., Seeger, W., Walmrath, D. (2000). Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange. J. Pharmacol. Exp. Ther. 292: 512-520 [Abstract] [Full Text]  
• Brundage, S. I, Maier, R. V (2000). Trauma intensive care. Trauma 2: 19-31 [Abstract]  
• Ferguson, N. D., Granton, J. T. (2000). Inhaled nitric oxide for hypoxemic respiratory failure: Passing bad gas?. CMAJ 162: 85-86 [Full Text]  
• Brook, A. D., Kollef, M. H. (1999). An Outcomes-Based Approach to Ventilatory Management: Review of Two Examples: Brook AD, Kollef MH An outcomes-based approach to ventilatory management review of two examples J Intensive Care Med 1999,14 262-274. J Intensive Care Med 14: 262-274  
• Black, S. M., Heidersbach, R. S., McMullan, D. M., Bekker, J. M., Johengen, M. J., Fineman, J. R. (1999). Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 277: H1849-H1856 [Abstract] [Full Text]  
• ROSE, F., ZWICK, K., GHOFRANI, H. A., SIBELIUS, U., SEEGER, W., WALMRATH, D., GRIMMINGER, F. (1999). Prostacyclin Enhances Stretch-induced Surfactant Secretion in Alveolar Epithelial Type II Cells. Am. J. Respir. Crit. Care Med. 160: 846-851 [Abstract] [Full Text]  
• Gross, S. S., Lane, P. (1999). Physiological reactions of nitric oxide and hemoglobin: A radical rethink. Proc. Natl. Acad. Sci. USA 96: 9967-9969 [Full Text]  
• Hayward, C. S, Kelly, R. P, Macdonald, P. S (1999). Inhaled nitric oxide in cardiology practice. Cardiovasc Res 43: 628-638 [Abstract] [Full Text]  
• Gow, A. J., Luchsinger, B. P., Pawloski, J. R., Singel, D. J., Stamler, J. S. (1999). The oxyhemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. USA 96: 9027-9032 [Abstract] [Full Text]  
• PAPAZIAN, L., ROCH, A., BREGEON, F., THIRION, X., GAILLAT, F., SAUX, P., FULACHIER, V., JAMMES, Y., AUFFRAY, J.-P. (1999). Inhaled Nitric Oxide and Vasoconstrictors in Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 160: 473-479 [Abstract] [Full Text]  
• OLSCHEWSKI, H., ARDESCHIR GHOFRANI, H., WALMRATH, D., SCHERMULY, R., TEMMESFELD-WOLLBRÜCK, B., GRIMMINGER, F., SEEGER, W. (1999). Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis. Am. J. Respir. Crit. Care Med. 160: 600-607 [Abstract] [Full Text]  
• WALLEY, K. R., MCDONALD, T. E., HIGASHIMOTO, Y., HAYASHI, S. (1999). Modulation of Proinflammatory Cytokines by Nitric Oxide in Murine Acute Lung Injury. Am. J. Respir. Crit. Care Med. 160: 698-704 [Abstract] [Full Text]  
• Moutafis, M., Dalibon, N., Colchen, A., Fischler, M. (1999). Improving Oxygenation During Bronchopulmonary Lavage Using Nitric Oxide Inhalation and Almitrine Infusion. Anesth. Analg. 89: 302-302 [Full Text]  
• Rolla, G., Brussino, L., Colagrande, P. (1999). Nitric Oxide and Impaired Oxygenation before and after Liver Transplantation. ANN INTERN MED 131: 69-69 [Full Text]  
• Suzuki, Y., Malekan, R., Hanson, C. W. III, Niewiarowski, S., Sun, L., Rao, A. K., Edmunds, L. H. Jr (1999). PLATELET ANESTHESIA WITH NITRIC OXIDE WITH OR WITHOUT EPTIFIBATIDE DURING CARDIOPULMONARY BYPASS IN BABOONS. J. Thorac. Cardiovasc. Surg. 117: 987-993 [Abstract] [Full Text]